Department of Anesthesiology, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA.
Mayo Clinic Medical Scientist Training Program, USA.
Adv Anesth. 2024 Dec;42(1):131-150. doi: 10.1016/j.aan.2024.07.010.
Remimazolam is a new reversible γ-aminobutyric acid type A agonist benzodiazepine that displays a fast onset of action, short recovery time with a safe cardiopulmonary profile and favorable pharmacokinetics in comparison with other intravenous sedatives.
瑞马唑仑是一种新型的γ-氨基丁酸 A 型受体激动剂苯二氮䓬类药物，与其他静脉镇静药物相比，它具有起效迅速、恢复时间短、心肺安全性良好和药代动力学特性优良的特点。
